Daping Hospital And The Research Institute Of Surgery Of The Third Military Medical University
Clinical trials sponsored by Daping Hospital And The Research Institute Of Surgery Of The Third Military Medical University, explained in plain language.
-
New combo therapy aims to boost immune attack on Hard-to-Treat colorectal cancer
Disease control Not yet recruitingThis study tests a new treatment for people with advanced colorectal cancer that has not responded to standard therapies. Participants receive a special type of radiation (high and low dose) to some tumors, followed by a combination of targeted therapy (TKI) and immunotherapy (an…
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New surgical wrap could slash leak risk in esophageal cancer patients
Disease control Not yet recruitingThis study tests a new surgical technique for people with esophageal cancer. The method uses a special dye to check blood flow to the stomach, then wraps the surgical connection with a piece of the patient's own stomach lining to prevent leaks. About 73 adults will take part to s…
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 26, 2026 05:00 UTC
-
New stroke surgery could eliminate second operation
Disease control Not yet recruitingThis study tests a new surgical technique called Expansion-floating Craniotomy (EC) for people with life-threatening brain swelling after a massive stroke. The standard surgery removes a piece of skull to relieve pressure but requires a second operation months later to replace th…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Blue dye could make thyroid cancer surgery safer and more precise
Disease control Not yet recruitingThis study tests whether injecting a blue dye (mitoxantrone) into the thyroid during robotic surgery helps surgeons find and remove cancer-containing lymph nodes while protecting the parathyroid glands. About 114 people with papillary thyroid cancer will be randomly assigned to g…
Phase: PHASE4 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New combo therapy targets hard-to-treat abdominal cancers in early trial
Disease control Not yet recruitingThis early-stage study tests a new treatment plan for people with stomach or colon cancer that has spread to the lining of the abdomen. The approach combines low-dose radiation to the whole abdomen, chemotherapy given directly into the abdomen, and an immunotherapy drug. The main…
Phase: PHASE1 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Robot uses one tiny cut to fight stomach cancer
Disease control Not yet recruitingThis study will test a new robotic surgery that uses only one small cut to remove stomach cancer. It includes 20 adults aged 18-75 with early or locally advanced stomach cancer. The main goal is to see if the procedure is safe and works well by tracking any problems during or wit…
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
New PET imaging could reveal where cancer drugs go in real time
Diagnosis Not yet recruitingThis study will test a new type of PET scan that uses a radioactive label to track an immunotherapy drug (ivonescimab) in the body. The goal is to see how well the drug reaches and binds to esophageal tumors without needing a biopsy. About 50 adults with esophageal cancer will re…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 26, 2026 05:04 UTC
-
New scan could reveal hidden tumors and guide cancer treatment
Diagnosis Not yet recruitingThis study tests a new type of PET scan that uses a special tracer to find tumors and check their PD-L1 levels, which helps decide if immunotherapy might work. About 50 adults with confirmed cancer and suspicious spots on scans will be imaged before any treatment. The goal is to …
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 26, 2026 05:02 UTC
-
Breakthrough scan could replace needle biopsies for fibrosis
Diagnosis Not yet recruitingThis study tests a new type of PET scan that uses a special tracer to find fibrosis (scarring) in organs like the lungs. It aims to see if this scan can diagnose fibrosis more safely and accurately than current methods, which often require invasive biopsies. The study will involv…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 26, 2026 05:01 UTC
-
New PET probe could spot lung scarring early
Diagnosis Not yet recruitingThis study tests a new type of PET scan that uses a special probe to find a protein called DDR2, which is linked to lung scarring in interstitial lung disease. The goal is to see if this scan can diagnose the disease earlier and more accurately than current methods. The study wil…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 20, 2026 11:56 UTC
-
New imaging agent aims to sharpen lung nodule diagnosis
Diagnosis Not yet recruitingThis study will test a new imaging drug called Trap-(FAPI)3 to see if it can improve PET scans for people with lung nodules. The drug is designed to stick to tumors more strongly and stay longer, which may help doctors find and diagnose lung nodules more accurately. About 50 adul…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 18, 2026 11:59 UTC
-
Gut health boost may fight cancer wasting in lung patients
Symptom relief Not yet recruitingThis study tests whether an oral postbiotic called JK-5G can help non-small-cell lung cancer patients with cachexia—a condition causing severe weight loss and muscle wasting. About 150 adults with advanced lung cancer will receive either JK-5G or a placebo for 12 weeks. The main …
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC